Billy Webber is the Chief Executive Officer of XR Therapeutics, leading the company’s mission to revolutionise mental health treatment through immersive technology. With over 15 years of experience in the UK tech sector, Billy has a proven track record in helping businesses to scale, secure investment, and navigating complex healthcare regulations.
He has successfully raised finance through Venture Capital and Angel Investment, leveraging SEIS and EIS schemes. Under his leadership, XR Therapeutics has expanded its presence within the NHS, embedding its innovative solutions across multiple trusts. Billy has also overseen the company obtaining medical device compliance and DTAC regulations, ensuring the company’s products meet the highest standards.
Prior to XR Therapeutics, Billy played a key role in supporting 100’s of tech entrepreneurs to grow and scale their businesses. His deep industry knowledge, strategic vision, and passion for innovation continue to drive XR Therapeutics’ growth and impact in the mental health space.